Neurodegenerative Disease Committee
Explore our initiatives to lower the burden of neurodegenerative diseases in Europe and beyond.
We envision a future where neurodegenerative diseases are effectively managed and ultimately prevented.
We are dedicated to advancing the understanding, treatment, and prevention of neurodegenerative diseases through collaborative research and innovation. By bringing together leading researchers, clinicians, and advocates, we work to accelerate scientific breakthroughs and translate discoveries into meaningful treatments that can improve outcomes for patients and families affected by these conditions.
We want patients and families worldwide to benefit from cutting-edge therapies, improved diagnostic tools, and comprehensive care approaches. Together, we are committed to driving progress in neurological research and ensuring that scientific advances lead to real-world improvements in the lives of those facing these challenging conditions.
It is imperative that funding goes hand in hand with academic dialogue.”
Committee members
Latest publications
All publications →-
Video Presentation
Ketogenic Strategies for Alzheimer’s Disease and Other Memory Impairments
This video explores 288 caregiver case reports along with the history and rationale of ketogenic strategies for Alzheimer’s disease.
Mary Newport -
Research Article
Real-Time Alzheimer’s Detection using Deep Vision Models
Early detection of Alzheimer’s disease is essential for timely intervention, but traditional diagnostic tools often fall short due to their reliance on manual evaluation and limited sensitivity.
Yashwanth Reddy Akkidi and Wisam Bukaita · Lawrence Technological University -
Policy Framework
Reducing the Burden of Neurodegenerative Diseases in Europe and Beyond
The European Society of Medicine emphasizes the urgent need to address the increasing burden of neurodegenerative diseases in Europe. This comprehensive policy framework provides a roadmap for tackling these complex conditions through advancements in diagnostics, treatment modalities, long-term management strategies, and equitable access to care.
-
Case Report
Case of Early-onset Dementia with Lewy Bodies Associated with PRKN Gene Mutation
This report reveals a potential unique association of the PRKN mutation with early-onset dementia with Lewy bodies.
Leila Lotfi and Neeraj Singh · Northwell Health Neurosciences Institute
Theme issues
Register as an author to contribute to a forthcoming issue.
Register to contribute- 01Disease-Modifying Therapies for Multiple Sclerosis
- 02Emerging Therapies for Huntington’s Disease
- 03Caregiver Support Systems in Dementia Care
- 04Digital Health Technologies for Neurodegenerative Disease
- 05Emerging Paradigms in Parkinson’s Disease Treatment